Study of STIM1 Membrane Expression
Study of STIM1 Membrane Expression During Autoimmune Diseases
University Hospital, Brest
670 participants
May 11, 2021
OBSERVATIONAL
Conditions
Summary
The aim of this study is to determine the expression of STIM1 in the plasma membrane of lymphocytes from patients suffering from different autoimmune diseases in order to identify new pathologies of interest presenting an over-expression of STIM1PM. This would allow to initiate, following this study, research and development programs on the use of anti-STIM1 antibodies in these identified autoimmune diseases of interest.
Eligibility
Inclusion Criteria1
- Diagnosis of one of the autoimmune diseases
Exclusion Criteria1
- Treatment with rituximab in the previous 12 months
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04978948